Analysis of Biomarkers and Marginal Bone Loss in Platform-Switched and Nonplatform-Switched Implants: A Randomized Clinical Trial.

Necla Asli Kocak-Oztug Gamze Zeynep Adem-Siyli Orkhan Abishev Sule Batu Yegane Guven Ali Cekici Aslan Y Gokbuget Erhan Firatli Serdar Cintan

Published in: BioMed research international (2022)

PS was superior to NPS regarding the preservation of MBL. Higher MCP-1 levels, altered RANKL/OPG ratio, and lower OPG levels in the NPS group could be associated with subclinical peri-implant bone remodeling.

Keyphrases

bone loss
high throughput
soft tissue
oxide nanoparticles
inflammatory response
body composition